Pharmacogenomics as a Competitive Strategy for Compounding Pharmacies
Author(s): Maham Nicole Y
Issue: Nov/Dec 2022 - Volume 26, Number 6
View All Articles in Issue
Page(s): 474-479
Download in electronic PDF format for $65
Abstract: Patients’ responses to medical treatment vary greatly; while many may benefit from pharmacological therapy, others may suffer from harmful drug reactions or show no response at all. To provide an effective individualized care, one must understand the elements that lead to varying patient outcomes and how these factors may interplay in an individual’s treatment outcome. Pharmacogenomics is the future of pharmacy, and there is a growing demand for this service. Compounding pharmacies are already at the forefront of meeting patients’ unique drug requirements. This gives them the opportunity to provide their patients with more valuable services than only selling drugs dictated by the formula! This article discusses pharmacogenomics as a competitive strategy for compounding pharmacies.
Related Keywords: Nicole Y. Maham, PharmD Candidate, MS(s) (Biomedical Science and IT Management), BS (Industrial Management), treatment outcomes, pharmacogenomics, drug response, personalized medicine, pharmacokinetics, pharmacodynamics, genetic polymorphism, genome-wide association studies, single-nucleotide polymorphisms, copy number variations, Clinical Pharmacogenomics Implementation Consortium, CPIC, gene-drug pairings, metabolizer phenotypes, pharmacogenomics implementation models, pharmacogenomic counseling, genetic counselors
Related Categories: BUSINESS, MARKETING, TECHNOLOGY, PATIENT ASSESSMENT, PROFESSIONAL ISSUES